Centrally acting agents like phentermine/topiramate and naltrexone/bupropion aid weight reduction but lack MASLD-specific ...
In new guidance to medics, the European Association for the Study of Obesity praised the drugs' effectiveness and significant ...
It has been used in clinical trials of two FDA-approved medications: a first-generation weight loss drug, phentermine-topiramate, and a newer GLP-1 drug called liraglutide. Those with a high satiation ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...
MedPage Today on MSN
Pick GLP-1s as First Drug Option in Obesity, Guidelines From Abroad Say
The European Association for the Study of Obesity recommends the GLP-1 injectables semaglutide and tirzepatide as first-line ...
A study published in 2019 found lower rates of obesity in people who smoked weed. But that doesn't necessarily mean weed makes you lose weight.
Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, ...
The European Association for the Study of Obesity (EASO) has called for GLP-1 agonists from Novo Nordisk and Eli Lilly to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback